atai Life Sciences (ATAI) Misses Q4 EPS by 9c

atai Life Sciences (NASDAQ: ATAI) reported Q4 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• FirstEnergy names Jon Dormo VP of generation project development
• Volkswagen plans to cut 50,000 jobs by 2030, shares gain